2018
Validation of the WHO Disability Assessment Schedule (WHODAS 2.0) 12‐item tool against the 36‐item version for measuring functioning and disability associated with pregnancy and history of severe maternal morbidity
Silveira C, Souza RT, Costa ML, Parpinelli MA, Pacagnella RC, Ferreira EC, Mayrink J, Guida JP, Sousa MH, Say L, Chou D, Filippi V, Barreix M, Barbour K, Firoz T, von Dadelszen P, Cecatti JG, Andreucci C, Andreucci C, Angelini C, Angelini C, Ferraz J, Ferraz J, Zanardi D, Zanardi D, Camargo R, Cottler S, Fawole O, Gadama L, Ghérissi A, Gyte G, Hindin M, Jayathilaka A, Kalamar A, Kone Y, Kostanjsek N, Lange I, Magee L, Mathur A, McCaw‐Binns A, Morgan M, Munjanja S, Gichuhi G, Petzold M, Sullivan E, Taulo F, Tunçalp Ö, Vanderkruik R. Validation of the WHO Disability Assessment Schedule (WHODAS 2.0) 12‐item tool against the 36‐item version for measuring functioning and disability associated with pregnancy and history of severe maternal morbidity. International Journal Of Gynecology & Obstetrics 2018, 141: 39-47. PMID: 29851113, PMCID: PMC6001571, DOI: 10.1002/ijgo.12465.Peer-Reviewed Original ResearchConceptsSevere maternal morbidityMaternal morbidityWHO Disability Assessment ScheduleTotal scoreRetrospective cohort studyDisability Assessment ScheduleInternal consistencyWHODAS-12Cohort studyPostpartum womenYear postpartumTertiary facilityAssessment ScheduleGood internal consistencySecondary analysisMorbidityMean differenceWomenConfirmatory factor analysisInstrument agreementLong-term repercussionsCronbach's alphaPregnancyAlpha coefficientScores
2014
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review
Firoz T, Magee L, MacDonell K, Payne B, Gordon R, Vidler M, von Dadelszen P, Group T. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG An International Journal Of Obstetrics & Gynaecology 2014, 121: 1210-1218. PMID: 24832366, PMCID: PMC4282072, DOI: 10.1111/1471-0528.12737.Peer-Reviewed Original ResearchConceptsOral antihypertensive agentsSevere hypertensionAntihypertensive agentsRelative riskOral antihypertensive therapySublingual nifedipine capsulesBlood pressure reductionRisk of strokePregnancy/postpartumResource-constrained settingsAntihypertensive therapyExperienced hypotensionOral labetalolOral nifedipineParenteral hydralazineFetal outcomesOral agentsPostpartum hypertensionDiastolic BPSystolic BPDATA COLLECTIONNifedipine capsulesTarget BPCochrane LibraryPostpartum women
2011
Postpartum evaluation and long term implications
Firoz T, Melnik T. Postpartum evaluation and long term implications. Best Practice & Research Clinical Obstetrics & Gynaecology 2011, 25: 549-561. PMID: 21536498, DOI: 10.1016/j.bpobgyn.2011.03.003.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseEarly-onset pre-eclampsiaPre-existing metabolic abnormalitiesTraditional cardiovascular risk factorsCardiovascular risk factorsPremature cardiovascular diseaseIschemic heart diseaseManagement of hypertensionHeart-healthy lifestyleLong-term implicationsPostpartum evaluationRenal diseaseMetabolic abnormalitiesPre-eclampsiaNext pregnancyWeeks postpartumHeart diseaseMonths postpartumPostpartum periodRisk factorsSecondary causesHigh riskHypertensionCare needsDisease pathophysiology